에스티팜과 mRNA 백신 최적화 LNP 기술 개발할 것 — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

Media Focus

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

Media Focus

Mar 26, 2021

에스티팜과 mRNA 백신 최적화 LNP 기술 개발할 것